Niki BioSolutions, Inc. (NasdaqCM: NIKI)
Health Care · Biotechnology · US
$4.65
+1.09% today · +98.3% 1Y
Niki BioSolutions, Inc. (NasdaqCM: NIKI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $13.52M and employs 1 people.
Over the last twelve months the share price has gained 98.3%, trading between 0.60 and 12.24.
Tweenvest scores Niki BioSolutions, Inc. across four factors: quality 35/100, value 74/100. Its strongest factor is value.
NIKI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.52M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -2.86
- Dividend yield
- —
- Beta (5Y)
- -1.00
- 52-week high
- $12.24
- 52-week low
- $0.60
- Avg volume (3M)
- —
- Shares outstanding
- 2.94M
- Employees
- 1
- Next earnings
- —
About Niki BioSolutions, Inc.
Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
- ISIN
- US6539421023
- Founded
- 2010
- Listed since
- Jul 20, 2026
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Initiator Pharma A/SOM: INIT | $13.85M | Skr1.75 | -13.79% |
| IN8bio, Inc.NasdaqCM: INAB | $13.80M | $1.40 | 0.00% |
| TME Pharma N.V.ENXTPA: ALTME | $13.67M | €0.12 | -6.01% |
| Synlogic, Inc.OTCPK: SYBX | $13.60M | $1.11 | -0.89% |
| Tempest Therapeutics, Inc.NasdaqCM: TPST | $13.42M | $0.79 | -2.44% |
| Aelis Farma SAENXTPA: AELIS | $13.39M | €0.88 | -4.89% |
| Passage Bio, Inc.NasdaqCM: PASG | $13.26M | $3.86 | -6.43% |
| Lisata Therapeutics, Inc.NasdaqCM: LSTA | $13.25M | $1.17 | -20.41% |
Figures last refreshed Oct 4, 2026.